MDS Pharma Services — Tempe, Arizona

MDS Pharma Services is a clinical research site located in Tempe, Arizona, United States 85283.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

MDS Pharma Services has participated in 4 clinical trials.

Therapeutic areas: Erectile Dysfunction, Healthy, Avanfil ADME.

Sponsors: VIVUS LLC, Kythera Biopharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tempe

Browse all research sites in Arizona · View every site in Tempe

• Tempe St. Luke's Hospital
• Arizona State University Health Services
• Arizona State University: Prevention Research Center
• Prevention Research Center Arizona State University
• Arizona State University
• Autism/Asperger's Research Group at Arizona State University
• Gateway Building, Room 361 & 363, Arizona State University
• Celerion
• Research Site
• Clinical Research Consortium
• Alliance for Multispecialty Research
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MDS Pharma Services?

MDS Pharma Services has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MDS Pharma Services conducted?

MDS Pharma Services has 4 clinical trials on record. Their work covers Erectile Dysfunction, Healthy, Avanfil ADME.

Is MDS Pharma Services accredited by Crixeo Clinical Trials?

MDS Pharma Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MDS Pharma Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.